Foto del docente

Marinella Roberti

Professoressa associata confermata

Dipartimento di Farmacia e Biotecnologie

Settore scientifico disciplinare: CHIM/08 CHIMICA FARMACEUTICA

Pubblicazioni

Manerba M.; Vettraino M.; Fiume L.; Di Stefano G.; Sartini A.; Giacomini E.; Buonfiglio R.; Roberti M.; Recanatini M., Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase., «CHEMMEDCHEM», 2012, 7, pp. 311 - 317 [articolo]

L. Garuti; M. Roberti; G. Bottegoni, Polo-like kinases inhibitors, «CURRENT MEDICINAL CHEMISTRY», 2012, 19, pp. 3937 - 3948 [articolo]

Bongarzone S; Tran HN; Cavalli A; Roberti M; Rosini M; Carloni P; Legname G; Bolognesi ML, Hybrid Lipoic Acid Derivatives to Attack Prion Disease on Multiple Fronts, «CHEMMEDCHEM», 2011, 6, pp. 601 - 605 [articolo]

L. Garuti; M. Roberti; G. Bottegoni, Irreversible protein kinase inhibitors, «CURRENT MEDICINAL CHEMISTRY», 2011, 14, pp. 2981 - 2994 [articolo]

Chiriano G.; Sartini A.; Mancini F.; Andrisano V.; Bolognesi M. L.; Roberti M.; Recanatini M.; Carloni P.; Cavalli A., Sequential Virtual Screening Approach to the Identification of Small Organic Molecules as Potential BACE-1 Inhibitors, «CHEMICAL BIOLOGY & DRUG DESIGN», 2011, 77, pp. 268 - 271 [articolo]

Roberti M; Bottegoni G.; Recanatini M., Multiple Ligand Strategy in anticancer drug discovery, in: Multifunctional Drugs: New Chimeras in Medicinal chemistry, PISA, Simona Rapposelli, 2010, pp. 217 - 242 [capitolo di libro]

L. Garuti; M. Roberti; G. Bottegoni, Non-ATP competitive protein kinase inhibitors, «CURRENT MEDICINAL CHEMISTRY», 2010, 17, pp. 2804 - 2821 [articolo]

Bongarzone S; Tran HN; Cavalli A; Roberti M; Carloni P; Legname G; Bolognesi ML., Parallel Synthesis, Evaluation, and Preliminary Structure-Activity Relationship of 2,5-Diamino-1,4-benzoquinones as a Novel Class of Bivalent Anti-Prion Compound., «JOURNAL OF MEDICINAL CHEMISTRY», 2010, 53, pp. 8197 - 81201 [articolo]

M. Roberti; B. Natalini; V. Andrisano; R. Seraglia; A. Gioiello; R. Pellicciari, Thermal and catalytic reactions of ethyl diazopiruvate with [60]fullerene, «TETRAHEDRON», 2010, 66, pp. 7329 - 7332 [articolo]

Kranjc A.; Bongarzone S.; Rossetti G.; Biarnes X.; Cavalli A.; Bolognesi M. L.; Roberti M.; Legname G.; Carloni P., Docking ligands on protein surfaces: the case study of prion protein., «JOURNAL OF CHEMICAL THEORY AND COMPUTATION», 2009, 5, pp. 2565 - 2573 [articolo]

Pizzirani D.; Roberti M.; Grimaudo S.; Di Cristina A.; Pipitone R.M.; Tolomeo M.; Recanatini M., Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells, «JOURNAL OF MEDICINAL CHEMISTRY», 2009, 52, pp. 6936 - 6940 [articolo]

L. Garuti; M.Roberti; G. Bottegoni, Small molecule aurora kinases inhibitors, «CURRENT MEDICINAL CHEMISTRY», 2009, 16, pp. 1949 - 1963 [articolo]

Pizzirani D.; Roberti M.; Cavalli A.; Grimaudo S.; Di Cristina A.; Pipitone R.M.; Gebbia N.; Tolomeo M.; Recanatini M., Antiproliferative agents that interfere with the cell cycle at the G(1)-->S transition: further development and characterization of a small library of stilbene-derived compounds, «CHEMMEDCHEM», 2008, 3, pp. 345 - 355 [articolo]

A. Kranjc; S. Bongarzone; G. Chiriano; G. Rossetti; X. Biarnés; A. Cavalli; M.L. Bolognesi; M. Roberti; G. Legname; P. Carloni, DESIGN OF LIGANDS WITH A HIGH AFFINITY TO PrPC, in: International Workshop HUMAN and ANIMAL TSE, Programme Abstracts, S. L., s. n., 2008, pp. 34 - 34 (atti di: International Workshop HUMAN and ANIMAL TSE, Grado, Italy, 26-28 Giugno 2008) [atti di convegno-abstract]

Xu X.; Recanatini M.; Roberti M.; Tseng G.-N., Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243), «MOLECULAR PHARMACOLOGY», 2008, 73, pp. 1709 - 1721 [articolo]

Ultimi avvisi

Al momento non sono presenti avvisi.